JP2004532830A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004532830A5 JP2004532830A5 JP2002573043A JP2002573043A JP2004532830A5 JP 2004532830 A5 JP2004532830 A5 JP 2004532830A5 JP 2002573043 A JP2002573043 A JP 2002573043A JP 2002573043 A JP2002573043 A JP 2002573043A JP 2004532830 A5 JP2004532830 A5 JP 2004532830A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine
- use according
- influenza
- virus
- delivery device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229960005486 vaccine Drugs 0.000 claims 10
- 206010022000 influenza Diseases 0.000 claims 7
- 239000000427 antigen Substances 0.000 claims 5
- 102000036639 antigens Human genes 0.000 claims 5
- 108091007433 antigens Proteins 0.000 claims 5
- 239000000463 material Substances 0.000 claims 5
- 241000700605 Viruses Species 0.000 claims 4
- 229960003971 influenza vaccine Drugs 0.000 claims 4
- 238000002360 preparation method Methods 0.000 claims 4
- 230000028993 immune response Effects 0.000 claims 3
- 125000000217 alkyl group Chemical group 0.000 claims 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical class C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims 2
- 229920000053 polysorbate 80 Polymers 0.000 claims 2
- 230000001681 protective effect Effects 0.000 claims 2
- 230000003612 virological effect Effects 0.000 claims 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 claims 1
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 claims 1
- 239000004380 Cholic acid Substances 0.000 claims 1
- 101710154606 Hemagglutinin Proteins 0.000 claims 1
- 101710093908 Outer capsid protein VP4 Proteins 0.000 claims 1
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 claims 1
- 101710176177 Protein A56 Proteins 0.000 claims 1
- 229920004890 Triton X-100 Polymers 0.000 claims 1
- 239000013504 Triton X-100 Substances 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 239000003613 bile acid Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 235000012000 cholesterol Nutrition 0.000 claims 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 claims 1
- 235000019416 cholic acid Nutrition 0.000 claims 1
- 229960002471 cholic acid Drugs 0.000 claims 1
- 238000005352 clarification Methods 0.000 claims 1
- 238000000432 density-gradient centrifugation Methods 0.000 claims 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 239000000185 hemagglutinin Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000002736 nonionic surfactant Substances 0.000 claims 1
- -1 nonylphenoxy Chemical group 0.000 claims 1
- 229920002114 octoxynol-9 Polymers 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 229920000056 polyoxyethylene ether Polymers 0.000 claims 1
- 229940051841 polyoxyethylene ether Drugs 0.000 claims 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims 1
- 229920000136 polysorbate Polymers 0.000 claims 1
- 239000001397 quillaja saponaria molina bark Chemical class 0.000 claims 1
- 229930182490 saponin Chemical class 0.000 claims 1
- 150000007949 saponins Chemical class 0.000 claims 1
- 241000712461 unidentified influenza virus Species 0.000 claims 1
- 210000000605 viral structure Anatomy 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0104538A GB0104538D0 (en) | 2001-02-23 | 2001-02-23 | Novel Vaccine |
| GB0104538.4 | 2001-02-23 | ||
| GB0107511A GB0107511D0 (en) | 2001-03-26 | 2001-03-26 | Novel vaccine |
| GB0107511.8 | 2001-03-26 | ||
| GB0108365A GB0108365D0 (en) | 2001-04-03 | 2001-04-03 | Novel compounds |
| GB0108365.8 | 2001-04-03 | ||
| PCT/EP2002/001844 WO2002074336A2 (en) | 2001-02-23 | 2002-02-21 | Influenza vaccine formulations for intradermal delivery |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009063830A Division JP5960380B2 (ja) | 2001-02-23 | 2009-03-17 | 新規なワクチン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004532830A JP2004532830A (ja) | 2004-10-28 |
| JP2004532830A5 true JP2004532830A5 (enExample) | 2005-12-22 |
| JP5208347B2 JP5208347B2 (ja) | 2013-06-12 |
Family
ID=27256080
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002573043A Expired - Fee Related JP5208347B2 (ja) | 2001-02-23 | 2002-02-21 | 新規なワクチン |
| JP2009063830A Expired - Fee Related JP5960380B2 (ja) | 2001-02-23 | 2009-03-17 | 新規なワクチン |
| JP2011201447A Expired - Fee Related JP6076592B2 (ja) | 2001-02-23 | 2011-09-15 | 新規なワクチン |
| JP2015084294A Expired - Fee Related JP6211555B2 (ja) | 2001-02-23 | 2015-04-16 | 新規なワクチン |
| JP2017134258A Pending JP2017186367A (ja) | 2001-02-23 | 2017-07-10 | 新規なワクチン |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009063830A Expired - Fee Related JP5960380B2 (ja) | 2001-02-23 | 2009-03-17 | 新規なワクチン |
| JP2011201447A Expired - Fee Related JP6076592B2 (ja) | 2001-02-23 | 2011-09-15 | 新規なワクチン |
| JP2015084294A Expired - Fee Related JP6211555B2 (ja) | 2001-02-23 | 2015-04-16 | 新規なワクチン |
| JP2017134258A Pending JP2017186367A (ja) | 2001-02-23 | 2017-07-10 | 新規なワクチン |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US20040071734A1 (enExample) |
| EP (3) | EP1361890B1 (enExample) |
| JP (5) | JP5208347B2 (enExample) |
| AT (1) | ATE503493T1 (enExample) |
| AU (1) | AU2002254901A1 (enExample) |
| CA (1) | CA2438942A1 (enExample) |
| CY (1) | CY1111553T1 (enExample) |
| DE (3) | DE60239594D1 (enExample) |
| DK (1) | DK1361890T3 (enExample) |
| PT (1) | PT1361890E (enExample) |
| WO (1) | WO2002074336A2 (enExample) |
Families Citing this family (84)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR025750A1 (es) * | 1999-09-24 | 2002-12-11 | Smithkline Beecham Biolog | Vacunas |
| WO2002067983A1 (en) * | 2001-02-23 | 2002-09-06 | Glaxosmithkline Biologicals S.A. | Novel vaccine |
| US20040071734A1 (en) | 2001-02-23 | 2004-04-15 | Nathalie Garcon | Novel vaccine |
| JP2004520144A (ja) * | 2001-04-27 | 2004-07-08 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 新規ワクチン |
| EP1416986A4 (en) * | 2001-06-29 | 2005-12-14 | Becton Dickinson Co | INTRADERMIC DISTRIBUTION OF VACCINES AND GENE THERAPEUTIC AGENTS VIA MICROCANNULE |
| CA2807534A1 (en) | 2003-02-25 | 2005-02-17 | Medimmune Vaccines, Inc. | Methods of producing influenza vaccine compositions |
| US20060110406A1 (en) | 2003-02-25 | 2006-05-25 | Medimmune Vaccines, Inc. | Refrigerator-temperature stable influenza vaccine compositions |
| US7588774B2 (en) | 2003-05-12 | 2009-09-15 | Becton, Dickinson And Company | Molecules enhancing dermal delivery of influenza vaccines |
| US20050123550A1 (en) * | 2003-05-12 | 2005-06-09 | Laurent Philippe E. | Molecules enhancing dermal delivery of influenza vaccines |
| US7566458B2 (en) | 2003-06-16 | 2009-07-28 | Medimmune, Llc | Influenza hemagglutinin and neuraminidase variants |
| DE202005022108U1 (de) | 2004-03-09 | 2013-11-12 | Novartis Vaccines And Diagnostics, Inc. | Influenza-Virus-Impfstoffe |
| KR101376889B1 (ko) * | 2004-10-06 | 2014-03-25 | 메디뮨 엘엘씨 | 냉장 온도 안정성 인플루엔자 백신 조성물 |
| EP2923711A1 (en) * | 2004-11-03 | 2015-09-30 | Novartis Vaccines and Diagnostics, Inc. | Influenza vaccination |
| ES2527503T3 (es) | 2005-03-08 | 2015-01-26 | Medimmune, Llc | Virus influenza reordenantes |
| TW200700079A (en) * | 2005-03-23 | 2007-01-01 | Glaxosmithkline Biolog Sa | Composition |
| JP4828189B2 (ja) * | 2005-09-14 | 2011-11-30 | 雅美 森山 | 分泌型ＩｇＡ及びＩｇＧ抗体誘導剤 |
| ES2359214T5 (es) | 2005-11-01 | 2014-10-08 | Novartis Vaccines And Diagnostics Gmbh | Vacunas virales derivadas de células con niveles reducidos de ADN celular residual por tratamiento con beta-propiolactona |
| BRPI0618254A2 (pt) | 2005-11-04 | 2011-08-23 | Novartis Vaccines & Diagnostic | emulsões com agente tensoativo de fase aquosa livre para fornecer adjuvante às vacinas contra influenza dividido |
| US20090304742A1 (en) | 2005-11-04 | 2009-12-10 | Novartis Vaccines And Diagnostics Srl | Influenza vaccines with reduced amount of emulsion adjuvant |
| PL1951299T3 (pl) | 2005-11-04 | 2012-07-31 | Novartis Ag | Szczepionki przeciw grypie zawierające kombinacje adiuwantów cząsteczkowych i czynników wzmacniających immunogenność |
| PL1945252T3 (pl) | 2005-11-04 | 2013-11-29 | Seqirus Uk Ltd | Szczepionki zawierające oczyszczone antygeny powierzchniowe otrzymane z wirusów grypy hodowanych w hodowli komórkowej i skwalen jako adiuwant |
| CN102755645A (zh) | 2005-11-04 | 2012-10-31 | 诺华疫苗和诊断有限公司 | 佐剂配制的包含细胞因子诱导剂的流感疫苗 |
| KR20080089663A (ko) | 2006-01-27 | 2008-10-07 | 노바티스 백신즈 앤드 다이아그노스틱스 게엠베하 운트 콤파니 카게 | 적혈구응집소 및 기질 단백질을 함유한 인플루엔자 백신 |
| JP2009534303A (ja) * | 2006-03-24 | 2009-09-24 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス ゲーエムベーハー アンド カンパニー カーゲー | 冷蔵しないインフルエンザワクチンの保存 |
| MX2009000660A (es) | 2006-07-17 | 2009-04-08 | Glaxosmithkline Biolog Sa | Vacuna de influenza. |
| GB0614460D0 (en) | 2006-07-20 | 2006-08-30 | Novartis Ag | Vaccines |
| WO2008032219A2 (en) | 2006-09-11 | 2008-03-20 | Novartis Ag | Making influenza virus vaccines without using eggs |
| US20080124355A1 (en) | 2006-09-22 | 2008-05-29 | David Gordon Bermudes | Live bacterial vaccines for viral infection prophylaxis or treatment |
| CN101553252A (zh) | 2006-12-06 | 2009-10-07 | 诺华有限公司 | 包含来自于四株流感病毒的抗原的疫苗 |
| US9452209B2 (en) | 2007-04-20 | 2016-09-27 | Glaxosmithkline Biologicals Sa | Influenza vaccine |
| MX2009013118A (es) * | 2007-06-14 | 2010-03-04 | Crucell Switzerland Ag | Vacuna intradermica contra la influenza. |
| HRP20120790T1 (hr) | 2007-06-27 | 2013-01-31 | Novartis Ag | Cjepiva protiv influence sa niskom koliäśinom aditiva |
| GB0810305D0 (en) | 2008-06-05 | 2008-07-09 | Novartis Ag | Influenza vaccination |
| WO2009081172A1 (en) | 2007-12-24 | 2009-07-02 | Novartis Ag | Assays for adsorbed influenza vaccines |
| US8506966B2 (en) * | 2008-02-22 | 2013-08-13 | Novartis Ag | Adjuvanted influenza vaccines for pediatric use |
| ES2535101T3 (es) | 2008-03-18 | 2015-05-05 | Novartis Ag | Mejoras en la preparación de antígenos en vacuna de virus de la gripe |
| US8591914B2 (en) * | 2008-07-11 | 2013-11-26 | Medimmune, Llc | Influenza hemagglutinin and neuraminidase variants |
| JP5182753B2 (ja) * | 2008-09-01 | 2013-04-17 | 富士フイルム株式会社 | インフルエンザ罹患リスクの予測方法 |
| JP2012507272A (ja) | 2008-11-05 | 2012-03-29 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 新規な方法 |
| EP2396032B1 (en) | 2009-02-10 | 2016-09-28 | Seqirus UK Limited | Influenza vaccines with reduced amounts of squalene |
| WO2010092476A1 (en) | 2009-02-10 | 2010-08-19 | Novartis Ag | Influenza vaccine regimens for pandemic-associated strains |
| WO2010092477A1 (en) | 2009-02-10 | 2010-08-19 | Novartis Ag | Influenza vaccines with increased amounts of h3 antigen |
| CA2763816A1 (en) | 2009-04-27 | 2010-11-04 | Novartis Ag | Adjuvanted vaccines for protecting against influenza |
| EP2401384B1 (en) | 2009-05-21 | 2012-10-03 | Novartis AG | Reverse genetics using non-endogenous pol i promoters |
| CN102666860B (zh) | 2009-07-31 | 2015-06-17 | 诺华股份有限公司 | 反向遗传系统 |
| CA2773637A1 (en) | 2009-09-10 | 2011-03-17 | Novartis Ag | Combination vaccines against respiratory tract diseases |
| SI2491117T1 (sl) | 2009-10-20 | 2014-03-31 | Novartis Ag | Izboljšani postopki reverzne genetike za pridobivanje virusov |
| GB0918830D0 (en) * | 2009-10-27 | 2009-12-09 | Glaxosmithkline Biolog Niederl | Process |
| BR112012028146A2 (pt) | 2010-05-06 | 2015-09-15 | Novartis Ag | compostos de peróxido orgânico para inativação de microorganismos |
| JP5876036B2 (ja) | 2010-05-21 | 2016-03-02 | ノバルティス アーゲー | インフルエンザウイルス再集合方法 |
| DK2575872T3 (da) | 2010-06-01 | 2020-10-19 | Seqirus Uk Ltd | Koncentrering af influenzavaccineantigener uden frysetørring |
| US20130243841A1 (en) | 2010-06-01 | 2013-09-19 | Novartis Ag | Concentration of vaccine antigens with lyophilization |
| WO2011154976A2 (en) | 2010-06-08 | 2011-12-15 | Panacea Biotec Limited | Improved influenza vaccine |
| US9517205B2 (en) | 2010-08-20 | 2016-12-13 | Seqirus UK Limited | Soluble needle arrays for delivery of influenza vaccines |
| GB201216121D0 (en) | 2012-09-10 | 2012-10-24 | Novartis Ag | Sample quantification by disc centrifugation |
| EP2768528A1 (en) | 2011-10-20 | 2014-08-27 | Novartis AG | Adjuvanted influenza b virus vaccines for pediatric priming |
| GB201120000D0 (en) * | 2011-11-20 | 2012-01-04 | Glaxosmithkline Biolog Sa | Vaccine |
| ES2628301T3 (es) | 2012-03-02 | 2017-08-02 | Seqirus UK Limited | Recombinación de virus de gripe |
| RU2599496C2 (ru) | 2012-03-06 | 2016-10-10 | Круселл Холланд Б.В. | Улучшенная вакцинация против гриппа |
| AU2013270793A1 (en) | 2012-06-04 | 2014-12-11 | Novartis Ag | Improved safety testing |
| GB201218195D0 (en) | 2012-10-10 | 2012-11-21 | Istituto Zooprofilattico Sperimentale Delle Venezie | Composition |
| AU2013354219A1 (en) | 2012-12-03 | 2015-07-02 | Novartis Ag | Reassortant influenza a viren |
| UY34506A (es) * | 2012-12-10 | 2014-06-30 | Fernando Amaury Ferreira Chiesa | Adyuvante de vacunación, preparación y vacunas que lo contienen |
| CN109045294A (zh) | 2013-01-10 | 2018-12-21 | 思齐乐 | 流感病毒免疫原性组合物及其应用 |
| HK1218511A1 (zh) | 2013-03-13 | 2017-02-24 | Novartis Ag | 乙型流感病毒重配 |
| JP2016521282A (ja) | 2013-05-10 | 2016-07-21 | ノバルティス アーゲー | インフルエンザワクチンにおけるナルコレプシーのリスクの回避 |
| DE202013005100U1 (de) | 2013-06-05 | 2013-08-26 | Novartis Ag | Influenza Virus Reassortierung |
| DE202013005130U1 (de) | 2013-06-05 | 2013-09-10 | Novartis Ag | Influenza Virus Reassortierung |
| JP2016521553A (ja) | 2013-06-06 | 2016-07-25 | ノバルティス アーゲー | インフルエンザウイルス再集合 |
| US20160287693A1 (en) | 2013-11-15 | 2016-10-06 | Novartis Ag | Removal of residual cell culture impurities |
| WO2016008039A1 (en) | 2014-07-14 | 2016-01-21 | Novicol International Holding Inc. | Microbicidal composition comprising an octoxynol and a quinolizidine alkaloid compound or a source thereof |
| US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
| JP6719388B2 (ja) * | 2014-12-25 | 2020-07-08 | テルモ株式会社 | 皮内投与インフルエンザワクチン組成物 |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| AU2016281904B2 (en) | 2015-06-26 | 2022-08-11 | Seqirus UK Limited | Antigenically matched influenza vaccines |
| WO2017005880A1 (en) | 2015-07-07 | 2017-01-12 | Seqirus UK Limited | Influenza potency assays |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| WO2019086463A1 (en) | 2017-10-30 | 2019-05-09 | Baxalta GmbH | Environmentally compatible detergents for inactivation of lipid-enveloped viruses |
| BR112021016778A2 (pt) | 2019-02-25 | 2021-11-16 | Seqirus Uk Ltd | Vacinas contra influenza multivalentes com adjuvante e usos |
| US11471497B1 (en) | 2019-03-13 | 2022-10-18 | David Gordon Bermudes | Copper chelation therapeutics |
| KR20220098370A (ko) | 2019-11-07 | 2022-07-12 | 세퀴러스 유케이 리미티드 | 감소된 입자 크기를 가지는 바이러스 백신을 제조하기 위한 조성물 및 방법 |
| US12576146B2 (en) | 2019-11-18 | 2026-03-17 | Seqirus UK Limited | Method for producing reassortant influenza viruses |
| US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
| US12537071B1 (en) | 2020-07-22 | 2026-01-27 | David Gordon Bermudes | Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins |
Family Cites Families (101)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US639A (en) | 1838-03-17 | of boston | ||
| US5520A (en) | 1848-04-18 | Oegan-pipb | ||
| US1274081A (en) * | 1917-05-10 | 1918-07-30 | Herman A Metz | Hypodermic needle. |
| US1436707A (en) * | 1921-08-10 | 1922-11-28 | American Platinum Works | Adjustable and safety regulating device for hypodermic needles |
| FR1001668A (fr) * | 1946-06-17 | 1952-02-26 | Seringue pour anesthésie tronculaire du maxillaire inférieur | |
| US2559474A (en) * | 1950-03-09 | 1951-07-03 | Sonco Inc | Hypodermic and spinal syringe |
| FR1072399A (fr) * | 1961-01-07 | 1954-09-13 | Injecteur intra-dermique | |
| US3400715A (en) * | 1966-01-04 | 1968-09-10 | Halvard J. Pederson | Attachment for injection apparatus |
| US3964482A (en) * | 1971-05-17 | 1976-06-22 | Alza Corporation | Drug delivery device |
| BE795384A (fr) * | 1972-02-14 | 1973-08-13 | Ici Ltd | Pansements |
| JPS52132590A (en) | 1976-04-27 | 1977-11-07 | Haabaato Bogeruman Jiyosefu | Injector |
| US4270537A (en) | 1979-11-19 | 1981-06-02 | Romaine Richard A | Automatic hypodermic syringe |
| JPS5695058A (en) | 1979-12-10 | 1981-08-01 | Toyo Jozo Kk | Microosyringe |
| DD155875A1 (de) | 1980-12-31 | 1982-07-14 | Willy Nordheim | Verfahren zur herstellung eines ballaststoffarmen inaktivierten influenzaimpfstoffes |
| US4436727A (en) | 1982-05-26 | 1984-03-13 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
| SE8205892D0 (sv) | 1982-10-18 | 1982-10-18 | Bror Morein | Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin |
| JPS6153226A (ja) * | 1984-08-24 | 1986-03-17 | Chemo Sero Therapeut Res Inst | 単純ヘルペスサブユニツトワクチンの精製方法 |
| US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
| JPH0688911B2 (ja) * | 1985-06-06 | 1994-11-09 | 国立予防衛生研究所長 | インフルエンザワクチン及びその製造方法 |
| CA1283827C (en) | 1986-12-18 | 1991-05-07 | Giorgio Cirelli | Appliance for injection of liquid formulations |
| GB8704027D0 (en) | 1987-02-20 | 1987-03-25 | Owen Mumford Ltd | Syringe needle combination |
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| CA1331443C (en) | 1987-05-29 | 1994-08-16 | Charlotte A. Kensil | Saponin adjuvant |
| US6056716A (en) * | 1987-06-08 | 2000-05-02 | D'antonio Consultants International Inc. | Hypodermic fluid dispenser |
| US5080648A (en) * | 1987-06-08 | 1992-01-14 | Antonio Nicholas F D | Hypodermic fluid dispenser |
| US5569190A (en) * | 1987-06-08 | 1996-10-29 | D'antonio; Nicholas F. | Hypodermic fluid dispenser |
| US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
| US4940460A (en) | 1987-06-19 | 1990-07-10 | Bioject, Inc. | Patient-fillable and non-invasive hypodermic injection device assembly |
| US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
| GB2206794A (en) | 1987-07-14 | 1989-01-18 | Richard Kiteley Power | Syringe |
| DE3734306A1 (de) | 1987-10-10 | 1989-04-27 | Pfeiffer Erich Gmbh & Co Kg | Austragvorrichtung fuer fliessfaehige medien |
| US5195526A (en) * | 1988-03-11 | 1993-03-23 | Michelson Gary K | Spinal marker needle |
| US5339163A (en) | 1988-03-16 | 1994-08-16 | Canon Kabushiki Kaisha | Automatic exposure control device using plural image plane detection areas |
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| FR2638359A1 (fr) | 1988-11-03 | 1990-05-04 | Tino Dalto | Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau |
| US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
| US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
| DE4005528C2 (de) | 1990-02-22 | 1998-01-15 | Pfeiffer Erich Gmbh & Co Kg | Austragvorrichtung für Medien |
| US5279581A (en) | 1990-05-09 | 1994-01-18 | Firth John R | Disposable self-shielding hypodermic syringe |
| US5190521A (en) | 1990-08-22 | 1993-03-02 | Tecnol Medical Products, Inc. | Apparatus and method for raising a skin wheal and anesthetizing skin |
| TW279133B (enExample) * | 1990-12-13 | 1996-06-21 | Elan Med Tech | |
| US5527288A (en) | 1990-12-13 | 1996-06-18 | Elan Medical Technologies Limited | Intradermal drug delivery device and method for intradermal delivery of drugs |
| DE4127887C1 (en) | 1991-08-22 | 1993-01-28 | Manfred Prof. Dr. 8520 Erlangen De Herbst | Subcutaneous medicine delivery device preventing needle from exceeding required depth - comprises tube attached with needle free to move on wedge shaped needle holder with needle penetration holes of different depth |
| GB9118204D0 (en) | 1991-08-23 | 1991-10-09 | Weston Terence E | Needle-less injector |
| SE9102652D0 (sv) | 1991-09-13 | 1991-09-13 | Kabi Pharmacia Ab | Injection needle arrangement |
| ZA929870B (en) | 1991-12-23 | 1993-08-18 | Duphar Int Res | Adjuvants |
| US5328483A (en) | 1992-02-27 | 1994-07-12 | Jacoby Richard M | Intradermal injection device with medication and needle guard |
| IL101720A (en) * | 1992-04-29 | 1998-09-24 | Mali Tech Ltd | Needle for syringe or the like |
| NZ253137A (en) | 1992-06-25 | 1996-08-27 | Smithkline Beecham Biolog | Vaccine comprising antigen and/or antigenic composition, qs21 (quillaja saponaria molina extract) and 3 de-o-acylated monophosphoryl lipid a. |
| US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
| US5569189A (en) | 1992-09-28 | 1996-10-29 | Equidyne Systems, Inc. | hypodermic jet injector |
| US5334144A (en) | 1992-10-30 | 1994-08-02 | Becton, Dickinson And Company | Single use disposable needleless injector |
| WO1994019013A1 (en) * | 1993-02-19 | 1994-09-01 | Smithkline Beecham Corporation | Influenza vaccine compositions containing 3-o-deacylated monophosphoryl lipid a |
| CN1124013A (zh) * | 1993-02-19 | 1996-06-05 | 史密丝克莱恩比彻姆公司 | 含3-邻位-脱酰基的单磷酰基脂质a的流感疫苗组合物 |
| EP0689454B2 (en) | 1993-03-23 | 2005-02-23 | SMITHKLINE BEECHAM BIOLOGICALS s.a. | Vaccine compositions containing 3-o deacylated monophosphoryl lipid a |
| IE68890B1 (en) * | 1993-04-08 | 1996-07-24 | Elan Med Tech | Intradermal delivery device |
| ES2370937T3 (es) * | 1993-09-13 | 2011-12-23 | Protein Sciences Corporation | Un método para producir vacunas antigripales polivalentes a base de hemaglutinina. |
| US6485729B1 (en) * | 1993-09-13 | 2002-11-26 | Protein Sciences Corporation | Neuraminidase-supplemented compositions |
| CA2171563A1 (en) | 1993-09-14 | 1995-03-23 | Eric Le Cheminant | Injection device |
| US5997501A (en) * | 1993-11-18 | 1999-12-07 | Elan Corporation, Plc | Intradermal drug delivery device |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| WO1995024176A1 (en) | 1994-03-07 | 1995-09-14 | Bioject, Inc. | Ampule filling device |
| US5466220A (en) | 1994-03-08 | 1995-11-14 | Bioject, Inc. | Drug vial mixing and transfer device |
| JPH07299143A (ja) | 1994-05-09 | 1995-11-14 | Kenji Tsubota | 医科用注射針 |
| AUPM873294A0 (en) | 1994-10-12 | 1994-11-03 | Csl Limited | Saponin preparations and use thereof in iscoms |
| US5599302A (en) | 1995-01-09 | 1997-02-04 | Medi-Ject Corporation | Medical injection system and method, gas spring thereof and launching device using gas spring |
| UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
| GB9620795D0 (en) * | 1996-10-05 | 1996-11-20 | Smithkline Beecham Plc | Vaccines |
| US5730723A (en) | 1995-10-10 | 1998-03-24 | Visionary Medical Products Corporation, Inc. | Gas pressured needle-less injection device and method |
| US7223739B1 (en) * | 1995-06-07 | 2007-05-29 | Powderject Vaccines, Inc. | Adjuvanted genetic vaccines |
| SE9502285D0 (sv) | 1995-06-22 | 1995-06-22 | Pharmacia Ab | Improvements related to injections |
| US5893397A (en) | 1996-01-12 | 1999-04-13 | Bioject Inc. | Medication vial/syringe liquid-transfer apparatus |
| GB9607549D0 (en) | 1996-04-11 | 1996-06-12 | Weston Medical Ltd | Spring-powered dispensing device |
| BR9705023A (pt) * | 1996-10-12 | 1998-12-01 | Luk Getriebe Systeme Gmbh | Veículo automotor |
| US5776107A (en) * | 1996-12-31 | 1998-07-07 | Delab | Injection device |
| PL190237B1 (pl) | 1997-04-01 | 2005-11-30 | Corixa Corp | Kompozycja adiuwantowa, szczepionka, sposób wytwarzania kompozycji adiuwantowej oraz zastosowanie |
| US5993412A (en) | 1997-05-19 | 1999-11-30 | Bioject, Inc. | Injection apparatus |
| US5944700A (en) | 1997-09-26 | 1999-08-31 | Becton, Dickinson And Company | Adjustable injection length pen needle |
| US6482176B1 (en) | 1997-11-27 | 2002-11-19 | Disetronic Licensing Ag | Method and device for controlling the introduction depth of an injection needle |
| IT1298087B1 (it) * | 1998-01-08 | 1999-12-20 | Fiderm S R L | Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni |
| JP4118399B2 (ja) | 1998-07-21 | 2008-07-16 | テルモ株式会社 | 注射針用穿刺調整具およびそれを備えた注射針組立体 |
| US6309374B1 (en) | 1998-08-03 | 2001-10-30 | Insite Vision Incorporated | Injection apparatus and method of using same |
| US6159472A (en) | 1998-11-16 | 2000-12-12 | Akzo Nobel N.V. | Intradermal Avian immunization with inactivated vaccines |
| KR100642044B1 (ko) | 1999-03-19 | 2006-11-10 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 백신 |
| DE60044084D1 (de) | 1999-06-04 | 2010-05-12 | Georgia Tech Res Inst | Vorrichtungen zur vergrösserten penetration von mikronadeln in biologischen hautschichten |
| US6623457B1 (en) * | 1999-09-22 | 2003-09-23 | Becton, Dickinson And Company | Method and apparatus for the transdermal administration of a substance |
| BR0014285A (pt) * | 1999-09-24 | 2002-05-21 | Smithkline Beecham Biolog | Adjuvantes compreendendo um éster ou éter de alquila de polioxietileno e pelo menos um tensoativo não-iÈnico |
| AR025750A1 (es) | 1999-09-24 | 2002-12-11 | Smithkline Beecham Biolog | Vacunas |
| US6569143B2 (en) * | 1999-10-14 | 2003-05-27 | Becton, Dickinson And Company | Method of intradermally injecting substances |
| US6776776B2 (en) * | 1999-10-14 | 2004-08-17 | Becton, Dickinson And Company | Prefillable intradermal delivery device |
| US6494865B1 (en) * | 1999-10-14 | 2002-12-17 | Becton Dickinson And Company | Intradermal delivery device including a needle assembly |
| US6569123B2 (en) * | 1999-10-14 | 2003-05-27 | Becton, Dickinson And Company | Prefillable intradermal injector |
| US8465468B1 (en) | 2000-06-29 | 2013-06-18 | Becton, Dickinson And Company | Intradermal delivery of substances |
| US20020193740A1 (en) * | 1999-10-14 | 2002-12-19 | Alchas Paul G. | Method of intradermally injecting substances |
| US6843781B2 (en) * | 1999-10-14 | 2005-01-18 | Becton, Dickinson And Company | Intradermal needle |
| DE19950530A1 (de) | 1999-10-20 | 2001-06-13 | Frank Neveling | Spritze zur intrakutanen Injektion |
| WO2002067983A1 (en) | 2001-02-23 | 2002-09-06 | Glaxosmithkline Biologicals S.A. | Novel vaccine |
| US20040071734A1 (en) | 2001-02-23 | 2004-04-15 | Nathalie Garcon | Novel vaccine |
| GB0109297D0 (en) * | 2001-04-12 | 2001-05-30 | Glaxosmithkline Biolog Sa | Vaccine |
| JP2004520144A (ja) * | 2001-04-27 | 2004-07-08 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 新規ワクチン |
| EP1416986A4 (en) * | 2001-06-29 | 2005-12-14 | Becton Dickinson Co | INTRADERMIC DISTRIBUTION OF VACCINES AND GENE THERAPEUTIC AGENTS VIA MICROCANNULE |
-
2002
- 2002-02-21 US US10/469,191 patent/US20040071734A1/en not_active Abandoned
- 2002-02-21 DE DE60239594T patent/DE60239594D1/de not_active Expired - Lifetime
- 2002-02-21 AT AT02724176T patent/ATE503493T1/de active
- 2002-02-21 PT PT02724176T patent/PT1361890E/pt unknown
- 2002-02-21 CA CA002438942A patent/CA2438942A1/en not_active Abandoned
- 2002-02-21 EP EP02724176A patent/EP1361890B1/en not_active Revoked
- 2002-02-21 WO PCT/EP2002/001844 patent/WO2002074336A2/en not_active Ceased
- 2002-02-21 DK DK02724176.9T patent/DK1361890T3/da active
- 2002-02-21 EP EP10178402.3A patent/EP2269639B1/en not_active Expired - Lifetime
- 2002-02-21 EP EP20100178427 patent/EP2281573A3/en not_active Withdrawn
- 2002-02-21 JP JP2002573043A patent/JP5208347B2/ja not_active Expired - Fee Related
- 2002-02-21 AU AU2002254901A patent/AU2002254901A1/en not_active Abandoned
-
2007
- 2007-06-13 US US11/762,488 patent/US8557251B2/en not_active Expired - Fee Related
-
2009
- 2009-03-17 JP JP2009063830A patent/JP5960380B2/ja not_active Expired - Fee Related
-
2011
- 2011-06-08 CY CY20111100550T patent/CY1111553T1/el unknown
- 2011-09-15 JP JP2011201447A patent/JP6076592B2/ja not_active Expired - Fee Related
- 2011-09-29 DE DE201112100053 patent/DE122011100053I1/de active Pending
- 2011-09-29 DE DE201112100054 patent/DE122011100054I1/de active Pending
- 2011-10-12 US US13/271,839 patent/US9138471B2/en not_active Expired - Fee Related
- 2011-10-12 US US13/271,810 patent/US20120029437A1/en not_active Abandoned
-
2015
- 2015-04-16 JP JP2015084294A patent/JP6211555B2/ja not_active Expired - Fee Related
-
2017
- 2017-07-10 JP JP2017134258A patent/JP2017186367A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004532830A5 (enExample) | ||
| JP2004536785A5 (enExample) | ||
| Karron et al. | Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants | |
| Herd et al. | Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice | |
| Kamili et al. | Protective efficacy of hepatitis E virus DNA vaccine administered by gene gun in the cynomolgus macaque model of infection | |
| NO20063157L (no) | Influensa-immunogen og vaksine | |
| Ma et al. | Vesicular stomatitis virus as a vector to deliver virus-like particles of human norovirus: a new vaccine candidate against an important noncultivable virus | |
| Hunziker et al. | Perspectives: towards a peptide-based vaccine against hepatitis C virus | |
| Wu et al. | A vesicular stomatitis virus-based mucosal vaccine promotes dendritic cell maturation and elicits preferable immune response against coxsackievirus B3 induced viral myocarditis | |
| Ishikawa | IMMUNOREGULATION OF HEPATITIS B VIRUS INFECTION―RATIONALE AND CLINICAL APPLICATION― | |
| Huhti et al. | Characterization and immunogenicity of norovirus capsid-derived virus-like particles purified by anion exchange chromatography | |
| US20220143175A1 (en) | Norovirus vaccines | |
| Bourgine et al. | Nasal route favors the induction of CD4+ T cell responses in the liver of HBV-carrier mice immunized with a recombinant hepatitis B surface-and core-based therapeutic vaccine | |
| Zhong et al. | CD4+ T cell priming accelerates the clearance of Sendai virus in mice, but has a negative effect on CD8+ T cell memory | |
| Boxus et al. | DNA immunization with plasmids encoding fusion and nucleocapsid proteins of bovine respiratory syncytial virus induces a strong cell-mediated immunity and protects calves against challenge | |
| Bhatnagar et al. | Comparison of the effects of different potent adjuvants on enhancing the immunogenicity and cross-protection by influenza virus vaccination in young and aged mice | |
| JP2009501901A5 (enExample) | ||
| JP7795861B2 (ja) | Ｂ型肝炎免疫化レジメン及び組成物 | |
| WO2009065800A1 (en) | Recombinant human adenoviruses for eliciting mucosal immune responses | |
| Carroll et al. | Alphavirus replicon-based adjuvants enhance the immunogenicity and effectiveness of Fluzone® in rhesus macaques | |
| Fu et al. | Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice | |
| Geissler et al. | Chronic ethanol effects on cellular immune responses to hepatitis B virus envelope protein: an immunologic mechanism for induction of persistent viral infection in alcoholics | |
| Hervás-Stubbs et al. | T-helper cell response to woodchuck hepatitis virus antigens after therapeutic vaccination of chronically-infected animals treated with lamivudine | |
| JP2022516041A (ja) | Ｂ型肝炎を治療するための薬物製剤、その製造方法及び用途 | |
| Wada et al. | DNA vaccine expressing the non-structural proteins of hepatitis C virus diminishes the expression of HCV proteins in a mouse model |